Ranolazine Article | 合法藥品大搜索

2021年6月29日—MechanismofAction...Themechanismofranolazine'santi-anginalandanti-ischemiceffectsisnotwellunderstood.Itinhibitslatesodium ...

This activity focuses on ranolazine, an FDA-approved medication for the management of chronic angina associated with ischemic heart disease. Aimed at optimizing the treatment of stable angina, the primary objective is to alleviate ischemic symptoms, minimize their occurrence, and reduce the risk of myocardial infarction and mortality. In conjunction with standard therapies such as aspirin, P2Y12 inhibitors, ACEIs, angiotensin receptor blockers, statins, beta-blockers, calcium channel blockers, and nitrates, ranolazine serves as an adjunct therapy, enriching the overall strategy for angina management.

This educational activity also explores the limited data surrounding ranolazines potential in addressing specific arrhythmias, particularly ventricular tachycardia. The program thoroughly explores ranolazine, encompassing its indications, mechanism of action, administration modalities, notable adverse e...